Matthias Treu

This inventor holds 16 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Boehringer Ingelheim International Gmbh, Vanderbilt University, Sanochemia Pharmazeutika Ag. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Treu. Retrieved from https://idiyas.com/inventor/matthias-treu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 18)

% Patents Active = 93.8

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 14(Granted Patents)

Company Filing History:

15 out of 1,562

Boehringer Ingelheim International Gmbh

patents

3 out of 1,221

Vanderbilt University

patents

1 out of 15

Sanochemia Pharmazeutika Ag

patents

where one patent can have more than one assignee

Years Active: 2007-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545670 - Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer (2026-02-10),

2. 12065427 - Heterocyclic compounds capable of activating STING (2024-08-20),

3. 12060367 - Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer (2024-08-13),

4. 11945812 - Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer (2024-04-02),

5. 11608343 - Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors (2023-03-21),

6. 11304929 - Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors (2022-04-19),

7. 10414769 - 5,8-dimethyl-9-phenyl-5,8-dihydro-6H-pyrazolo[3,4-h]quinazolin-2-yl)-(1H-pyrazol-3-yl)-amines as IGF-1R/IR inhibitors (2019-09-17),

8. 9150578 - [object Object] (2015-10-06),

9. 8853420 - Compounds (2014-10-07),

10. 8735386 - Aminopyrazoloquinazolines (2014-05-27),

11. 8623887 - Compounds (2014-01-07),

12. 8546443 - Benzylic oxindole pyrimidines (2013-10-01),

13. 8207179 - Substituted indolines as tyrosine kinase inhibitors (2012-06-26),

14. 7981880 - 3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors (2011-07-19),

15. 7714010 - Pyrrolobenzimidazolones and their use as anti-proliferative agents (2010-05-11),

Title: The Innovative Mind of Matthias Treu

Introduction: Matthias Treu, a visionary inventor hailing from Vienna, Austria, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Matthias Treu holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Matthias Treu has worked with leading research institutions and tech companies to bring his ideas to life. His innovative solutions have revolutionized various industries, earning him a reputation as a pioneer in his field.

Collaborations: Matthias Treu has collaborated with top engineers, scientists, and designers from around the globe, fostering a culture of creativity and excellence. His partnerships have led to the development of cutting-edge products that have had a lasting impact on society.

Conclusion: In conclusion, Matthias Treu's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His inventive spirit continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.